Showing results (311-320 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Humoral and cellular immunotherapy in ALL in children, adolescents, and young adultsJessica Hochberg, Nader Kim El-Mallawany, Mitchell S CairoClinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Biology and treatment of myelomaAnnamaria Brioli, Lorenzo Melchor, Brian A Walker, et al.Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Novel drug combinations for the management of relapsed/refractory multiple myelomaSaad Z Usmani, Sagar LonialClinical Lymphoma, Myeloma & Leukemia|December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapyMindy Leech, Lawrence Morris, Moishe Stewart, et al.Clinical Lymphoma, Myeloma & Leukemia|July 26, 2015
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community SettingNicholas J Di Bella, Debajyoti Bhowmik, Menaka Bhor, et al.Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysisRachel L Police, Peter C Trask, Jianmin Wang, et al.Clinical Lymphoma, Myeloma & Leukemia|September 2, 2014
R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphomaZachary Frosch, Marlise R Luskin, Daniel J Landsburg, et al.Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI ScoreFotios V Michelis, Hans A Messner, Jieun Uhm, et al.Clinical Lymphoma, Myeloma & Leukemia|December 4, 2014
Absolute lymphocyte count at day 29 of treatment is a powerful predictor of outcome in multiple myelomaVishal Narwani, Joseph Gabriel, Kevin Boyd, et al.Clinical Lymphoma, Myeloma & Leukemia|November 21, 2020
Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From GermanyMonika Engelhardt, Gabriele Ihorst, Moushmi Singh, et al.Pageof 251